FDA Unveils Sweeping Changes to Opioid Policy

Discussion in 'Daiichi-Sankyo' started by anonymous, Feb 6, 2016 at 10:02 PM.

Tags: Add Tags
  1. #1 anonymous, Feb 6, 2016 at 10:02 PM
    anonymous

    anonymous Guest

    The FDA will convene an expert advisory committee before approving any new drug application for an opioid that does not have abuse-deterrent properties.

    So much for CL-108
     
    Quote

  2. #2 anonymous, Feb 6, 2016 at 10:48 PM
    anonymous

    anonymous Guest


    Ouch... Just looked this up.
     
    Quote
  3. #3 anonymous, Feb 7, 2016 at 8:07 AM
    anonymous

    anonymous Guest

    CL-108 is officially dead. RIP! KK may move up the next round of layoffs.
     
    Quote
  4. #4 anonymous, Feb 7, 2016 at 8:30 AM
    anonymous

    anonymous Guest

    Karma is a Bitch. Serves Ken, and Rob rightfully so. Ha ha ha make that the second company walking dead boy has put out to pasture. Rob I believe that you have failed, that you have failed. Steve how is your value proposition working now you dolt. Next picture they should show at the National sales meeting is a grave stone: DSI 1997-2016, Ken Keller the Zombies finally got you!
     
    Quote
Reply to Thread